Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2025)
Fennec Pharmaceuticals posted quarterly Treasury Shares of $387000.0 for Q4 2025, up 19.44% year-on-year from $324000.0 in Q4 2024, and down 7.64% on a QoQ basis from $419000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 5 years of Treasury Shares data on file, last reported at $387000.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares rose 19.44% year-over-year to $387000.0; the trailing twelve-month figure through Dec 2025 stood at $387000.0 (up 19.44% YoY), and the FY2025 full-year result was $387000.0, up 19.44% from the prior year.
- Treasury Shares for Q4 2025 stood at $387000.0, down from $419000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $589000.0 in Q1 2025 and bottomed at $35000.0 in Q4 2022.
- The 5-year median for Treasury Shares is $219000.0 (2021), against an average of $248315.8.
- The widest annual swing landed in 2022, when Treasury Shares plunged 84.02%; it then jumped 522.86% in 2023.
- A 5-year view of Treasury Shares shows it stood at $219000.0 in 2021, then slumped by 84.02% to $35000.0 in 2022, then surged by 522.86% to $218000.0 in 2023, then surged by 48.62% to $324000.0 in 2024, then gained by 19.44% to $387000.0 in 2025.
- The last three Treasury Shares figures came in at $387000.0 (Q4 2025), $419000.0 (Q3 2025), and $100000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 387,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 387,000.00 |
| Dec 31, 2025 | 387,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 445,000.00 |
| Jun 30, 2024 | 445,000.00 |
| Mar 31, 2024 | 214,000.00 |
| Mar 31, 2024 | 214,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Sep 30, 2023 | 260,000.00 |
| Sep 30, 2023 | 260,000.00 |
| Jun 30, 2023 | 376,000.00 |
| Jun 30, 2023 | 376,000.00 |
| Mar 31, 2023 | 298,000.00 |
| Mar 31, 2023 | 298,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 123,000.00 |
| Jun 30, 2022 | 123,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Mar 31, 2022 | 131,000.00 |
| Dec 31, 2021 | 219,000.00 |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 55,000.00 |
| Sep 30, 2021 | 55,000.00 |
| Jun 30, 2021 | 55,000.00 |
| Jun 30, 2021 | 55,000.00 |